How one family’s cancer story turned into hope for millions
Multiple cancer diagnoses and a shared hereditary gene spurred Barbara Van Hare’s family to launch the Rare Cancer Research Foundation
Multiple cancer diagnoses and a shared hereditary gene spurred Barbara Van Hare’s family to launch the Rare Cancer Research Foundation
Illumina spotlights multiomics, rare disease innovation, and pediatric genomics at the UK’s largest life sciences event
How Dubai Health is swiftly scaling its genomics capabilities to improve health outcomes and fuel research for underrepresented populations
Illumina’s Patient Advocacy team connects patient organizations, scientific research, and community support to transform lives
| Date | Publication | Title |
|---|---|---|
| 23 Jun. 2025 | Endpoints News | Illumina to buy SomaLogic for $350M upfront, pushing further into proteomics |
| 17 Jun. 2025 | Forbes | Illumina’s New CIO Brings R&D Mindset As AI Transforms Genomics |
| 13 Jun. 2025 | GEN | Silver Anniversary of the Human Genome Project |
| 13 Jun. 2025 | GEN | Proteomics Partnerships Move Multiomics from Theory to Practice |
| 12 Jun. 2025 | Colorado State University | The pathogen hunter: Next-Generation Sequencing tracks down genetic mutations |

At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsIf you are a member of the media:
If you are not a member of the media, please visit Contact Us.